Search results for "PCOS"
showing 10 items of 63 documents
Estroprogestins and cardiovascular risk in Polycystic Ovary Syndrome
2013
Because PCOS women present an increased cardiovascular risk, the safety of estroprogestin treatment is debated and contrasting data have been reported. However, cardiovascular risk is not the same in all PCOS women and individual cardiovascular risk should be assessed before staring any estroprogestin treatment. The available data show that products containing both second generation and third generation progestins (including drosperinone and cyproterone acetate) represent a safe treatment in PCOS patients with regular cardiovascular risk. In PCOS patients with increased cardiovascular risk, a careful choice of estroprogestin product is needed and cardiovascular risk should be monitored duri…
Impact of obesity, insulin resistance and hyperandrogenism on steatosis and fibrosis risk in young females with PCOS
2017
Obesity and insulin resistance (IR) represent a common pathogenic background of polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease (NAFLD). We evaluated whether PCOS is a risk factor for steatosis, and subsequently, the impact of IR and hyperandrogenism on steatosis and fibrosis. We considered 202 consecutive non diabetic PCOS patients and 101 age-matched controls. PCOS was diagnosed applying the Rotterdam diagnostic criteria. Steatosis was diagnosed if hepatic steatosis index (HSI) >36, while fibrosis by using the FIB-4 score. As surrogate estimate of insulin sensitivity we considered the insulin sensitivity index (ISI). Free androgen index (FAI) was calculated as estima…
Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS.
2007
Introduction to the special issue: 2012 AE-PCOS meeting
2013
No abstract available
Editorial
2012
Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause
2013
Context: Polycystic ovary syndrome (PCOS) is diagnosed during the reproductive years when women present with 2 of 3 of the following criteria: 1) irregular menstrual cycles or anovulation, 2) hyperandrogenism, and 3) PCO morphology. However, there is evidence that PCOS can be identified from early infancy to puberty based on predisposing environmental influences. There is also increasing information about the PCOS phenotype after menopause. The goal of this review is to summarize current knowledge about the appearance of PCOS at different life stages and the influence of reproductive maturation and senescence on the PCOS phenotype. Evidence: PubMed, the bibliography from the Evidence-Based …
Consensus On Women'S Health Aspects Of Polycystic Ovary Syndrome (Pcos)
2012
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females with a high prevalence. The etiology of this heterogeneous condition remains obscure and its phenotype expression varies. Two, widely cited, previous ESHRE/ASRM-sponsored PCOS consensus workshops focused on diagnosis (published in 2004) and infertility management (published in 2008). The present third PCOS consensus paper summarizes current knowledge and identifies knowledge gaps regarding various women's health aspects of PCOS. Relevant topics addressed-all dealt with in a systematic fashion-include adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, preg…
In PCOS women AMH circulating levels predict patients who become ovulatory with aging.
2011
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS
2018
Background La sindrome dell’ovaio policistico (PCOS) è associata ad un aumentato rischio metabolico, sebbene una relazione diretta con le singole componenti caratterizzanti la PCOS è stata valutata in pochi studi. Scopo Valutare l’influenza dei principali parametri clinico-biochimici caratterizzanti la PCOS su due indici di rischio metabolico, il visceral adiposity index (VAI), associato a disfunzione adiposa viscerale e aumentato rischio cardiometabolico nella popolazione generale, e l’hepatic steatosis index (HSI), indice clinico di steatosi epatica. Materiali e Metodi Abbiamo valutato gli indici VAI e HSI in 202 pazienti con PCOS alla diagnosi, confrontate con 101 controlli sani appaiati…
Valoración del estado periodontal, perfil inflamatorio y disfunción endotelial en pacientes con Síndrome de Ovario Poliquístico
2022
Las enfermedades periodontales (PDs [del inglés, Periodontal Diseases]) son unas de las enfermedades más frecuentes. Estas patologías, son infecciosas - causadas por bacterias- y su naturaleza de inflamación crónica las ha relacionado con múltiples enfermedades sistémicas. Recientemente, se ha planteado la asociación de las PDs con el Síndrome de Ovario Poliquístico (PCOS [del inglés, Polycistic Ovary Syndrome]). Este síndrome, es un trastorno endocrino complejo cuyo criterio diagnóstico según el Consenso de Róterdam, contempla la presencia de oligo y/o anovulación, signos clínicos y/o bioquímicos de hiperandrogenismo y ovarios de apariencia ecográfica poliquística. La estimulación y secrec…